Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3754942, 10 pages
https://doi.org/10.1155/2017/3754942
Research Article

Sodium Ferulate Protects against Angiotensin II-Induced Cardiac Hypertrophy in Mice by Regulating the MAPK/ERK and JNK Pathways

Emergency Department, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China

Correspondence should be addressed to Dong-Xing Liu; moc.361@11uil_gnixgnod

Received 17 July 2016; Revised 18 October 2016; Accepted 2 November 2016; Published 10 January 2017

Academic Editor: Sung-Hoon Kim

Copyright © 2017 Bo Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Zhang, Y. Cao, H. Duan, H. Wang, and L. He, “Imperatorin prevents cardiac hypertrophy and the transition to heart failure via NO-dependent mechanisms in mice,” Fitoterapia, vol. 83, no. 1, pp. 60–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Grossman and W. J. Paulus, “Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling,” Journal of Clinical Investigation, vol. 123, no. 9, pp. 3701–3703, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. B. Wu, Y. Zhou, C. L. Liang et al., “Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway,” Chinese Journal of Integrative Medicine, 2016. View at Publisher · View at Google Scholar
  4. H. Yamakawa, T. Imamura, T. Matsuo et al., “Diastolic wall stress and ANG II in cardiac hypertrophy and gene expression induced by volume overload,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 279, no. 6, pp. H2939–H2946, 2000. View at Google Scholar · View at Scopus
  5. N. H. Purcell, B. J. Wilkins, A. York et al., “Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 35, pp. 14074–14079, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Cipolletta, M. R. Rusciano, A. S. Maione et al., “Targeting the CaMKII/ERK interaction in the heart prevents cardiac hypertrophy,” PLoS ONE, vol. 10, no. 6, Article ID e0130477, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Liu, L. Peng, J. Yang et al., “Sodium ferulate reduces portal pressure through inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase in cirrhotic rats,” Digestive Diseases and Sciences, vol. 60, no. 7, pp. 2019–2029, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Jin, E.-Z. Yan, Y. Fan, Z.-H. Zong, Z.-M. Qi, and Z. Li, “Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/protein kinase B in rat hippocampus,” Acta Pharmacologica Sinica, vol. 26, no. 8, pp. 943–951, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Brücken, A. B. Kaab, K. Kottmann et al., “Reducing the duration of 100% oxygen ventilation in the early reperfusion period after cardiopulmonary resuscitation decreases striatal brain damage,” Resuscitation, vol. 81, no. 12, pp. 1698–1703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Yan, L. R. Guo, Q. Zhang et al., “Chronic blockade of class I PI3-kinase attenuates Ang II-induced cardiac hypertrophy and autophagic alteration,” European Review for Medical and Pharmacological Sciences, vol. 19, no. 5, pp. 772–783, 2015. View at Google Scholar · View at Scopus
  11. T. G. von Lueder, B. H. Wang, A. R. Kompa et al., “Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy,” Circulation: Heart Failure, vol. 8, no. 1, pp. 71–78, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. O. J. Tsotetsi, A. J. Woodiwiss, M. Netjhardt, D. Qubu, R. Brooksbank, and G. R. Norton, “Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats,” Hypertension, vol. 38, no. 4, pp. 846–851, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Jain, N. Atale, S. Kohli, S. Bhattacharya, M. Sharma, and V. Rani, “An assessment of norepinephrine mediated hypertrophy to apoptosis transition in cardiac cells: a signal for cell death,” Chemico-Biological Interactions, vol. 225, pp. 54–62, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. He-nan, W. Yan, J. Miao-na, Z. Cai-hua, L. Shen, and J. Yu-jie, “Relation of Cardiotrophin-1 (CT-1) and cardiac transcription factor GATA4 expression in rat's cardiac myocytes hypertrophy and apoptosis,” Pathology Research and Practice, vol. 205, no. 9, pp. 615–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Barone-Rochette, S. Piérard, S. Seldrum et al., “Aortic valve area, stroke volume, left ventricular hypertrophy, remodeling, and fibrosis in aortic stenosis assessed by cardiac magnetic resonance imaging: comparison between high and low gradient and normal and low flow aortic stenosis,” Circulation: Cardiovascular Imaging, vol. 6, no. 6, pp. 1009–1017, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. M. Kreusser, L. H. Lehmann, S. Keranov et al., “Cardiac CaM kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy,” Circulation, vol. 130, no. 15, pp. 1262–1273, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Gu, W. Hu, Z. P. Song, Y. G. Chen, D. D. Zhang, and C. Q. Wang, “Rapamycin inhibits cardiac hypertrophy by promoting autophagy via the MEK/ERK/Beclin-1 pathway,” Frontiers in Physiology, vol. 7, article 104, 2016. View at Publisher · View at Google Scholar
  18. C. Ruppert, K. Deiss, S. Herrmann et al., “Interference with ERKThr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 18, pp. 7440–7445, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Chen, Z.-W. Chen, Z.-J. Long, J.-L. Liu, H.-W. Gao, and Y.-J. Wang, “Effects of sapindus saponins on inflammatory response mediated by AngII/p38MAPK pathway and cardiac hypertrophy in spontaneously hypertensive rats,” China Journal of Chinese Materia Medica, vol. 38, no. 7, pp. 1030–1035, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Jin, E.-Z. Yan, Y. Fan et al., “Neuroprotection by sodium ferulate against glutamate-induced apoptosis is mediated by ERK and PI3 kinase pathways,” Acta Pharmacologica Sinica, vol. 28, no. 12, pp. 1881–1890, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. K. Perera, J. U. Sprenger, J. H. Steinbrecher et al., “Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy,” Circulation Research, vol. 116, no. 8, pp. 1304–1311, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Rizzi, C. S. Ceron, D. A. Guimaraes et al., “Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy,” Experimental and Molecular Pathology, vol. 94, no. 1, pp. 1–9, 2013. View at Publisher · View at Google Scholar · View at Scopus